Dose Modification Requirement for Trelagliptin in Egyptian Population

NCT04374864 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus

Interventions

DRUG: Trelagliptin

Sponsor

British University In Egypt

Collaborators

[object Object]
[object Object]
[object Object]